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Polyvinyl chloride (PVC) is widely used in medical
devices because of its specific properties, including flexibility,
obtained after the addition of plasticizers (phthalates). Latex
is a natural elastomer used for surgical gloves and condoms.
Either PVC and latex devices should be non-toxic, eliciting
no adverse response.1
Phthalates present in PVC cause adverse effects in
rodent liver, kidney, and - for selected phthalates - in thyroid
gland tissue and testes. Medical devices containing di-(2-
ethylhexyl) phthalate are a source of significant exposure in
a susceptible subpopulation of individuals, especially those
undergoing intensive care, platelet transfusion, hemodialysis
and extracorporal membrane oxygenation (ECMO) in
newborns.2
Thirteen latex allergens have been identified and
isolated from natural rubber latex. Latex proteins present in
surgical gloves and condoms can cause type I immediate
hypersensitivity reaction, besides of type IV delayed
hypersensitivity reaction caused by the chemicals added to
latex during processing. Chemicals present in latex surgical
gloves and condoms comprise accelerators like mercapto-
benzothiazole, thiurams and carbamates, and antioxidants
such as various amines. Clinical manifestations of latex allergy
depend on the route of exposure and occur by direct contact
either with skin, mucosa, or by inhalation.2
Biomaterials are assigned cytotoxicity ratings based
on visual evidence of morphological cellular changes,
including cell lysis, rounding, spreading, and proliferation.
An accurate and precise in vitro cytotoxicity assay reduces
the number of animal studies needed to develop a new medical
device. The US FDA guidelines for medical device evaluation
are in concordance with ISO-10993 requirements (FDA G95-
1,1995)3 so that medical device cytotoxicity may be evaluated
according to ISO-10993-5 recommendations, with a visual
scoring method. In contrast, the Japanese Ministry for Health
and Welfare applies a more stringent standard for medical
device approval and specifies that medical device cytotoxicity
be evaluated using a quantitative assessment of surviving
cells (MHW notification no. 99, 1995). In this issue the article
"Evaluation of Brazilian Medical Devices using Agar Difusion
Cytotoxicity Assay" by Mirian Noemi Pinto Vidal, Claudia
Aiub, Shirley Abrantes and Helena P. da S. Zamith4 it is
described the use of L-929 mammalian fibroblast cells
cushioned in red agar (viable cells depicted by the red
presence on its citoplasm), in contact with PVC and latex
samples no more than 25mm2 (blood bags, catheters,
intravenous equipos, condoms) to evaluate cytotoxicity
(cellular degeneration and malformation) which was scored
from 0 to 4. Using this method it was observed an increase in
the quality (citotoxicity decrease) in the quality of the Brazilian
Medical Device products from 2000-2007 which can lead to
an improvement in the population health.
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